Cataract-Surgery Adjuncts Improve Vision in Diabetic Macular Edema

Source: Reuters

Both intravitreous bevacizumab (BVB) and triamcinolone acetate (TA) improve outcomes when given as an adjunct to cataract surgery in patients with diabetic macular edema (DME), a new randomized controlled trial shows., according to a Reuters report.

But improvement in central macular thickness (CMT) was sustained only in those who received TA, Dr. Rathika Kandasamy of the Royal Victorian Eye and Ear Hospital in East Melbourne, Australia, and colleagues found.

DME is associated with worse visual outcomes after cataract surgery, while the surgery itself may promote inflammation and in turn worsen DME, the authors note in the British Journal of Ophthalmology, online February 28.